BioInformant

Your Global Leader in Stem Cell Market Research

MENUMENU
  • Blog
  • Stem Cells
    • iPS Cells
    • MSCs
    • HSCs
    • Adipose SCs
    • Neural Stem Cells
  • Cell Therapy
    • COVID-19
    • CAR-T
    • Cord Blood
  • Exosomes
  • Interviews
  • News
    • Press Releases
    • Job Posts
  • Shop
    • Products
    • Submit PR
    • Advertise
  • About
    • Testimonials
    • Story
    • Guarantee
    • Contact
  • Home
  • Blog
    • Stem Cells
      • HSCs
      • iPS Cells
      • MSCs
      • Neural Stem Cells
      • Adipose SCs
    • Exosomes
    • Cell Therapy
      • CAR-T
    • Cord Blood
    • Stem Cell News
    • Interviews
  • COVID-19
  • Shop
  • Submit PR
  • Company
    • Advertise
    • Testimonials
    • Story
    • Job Posts
    • Guarantee
    • Privacy Policy
    • Contact
Home » placental

What are Placental Stem Cells and What are They Used For?

October 4, 2020 By Cade Hildreth (CEO) Leave a Comment

what are placental stem cells

What are placental stem cells and what are placental stem cells used for? As placental stem cells get explored for a variety of therapeutic applications, these questions become increasingly important. The opportunity to collect placental stem cells is also a once in a lifetime opportunity. [Read more…]

Filed Under: Cord Blood, MSCs Tagged With: Celularity, placental, Pluristem Therapeutics

Pluristem Therapeutics, Interview with Yaky Yanay, President and Co-CEO

March 28, 2019 By Cade Hildreth (CEO) 1 Comment

Placental cell therapies

Pluristem TherapeuticsPluristem Therapeutics (PSTI) is a clinical-stage company that is a proprietary 3D manufacturing technology to develop placental cell therapies for conditions that include ischemia, muscle injury, and exposure to radiation. I had the honor of interviewing Mr. Yaky Yanay, President and Co-CEO of Pluristem Therapeutics.

In this interview, we discuss the history of Pluristem Therapeutics, its clinical-stage products, intellectual property (IP) portfolio, marketing strategy and future directions.

Enjoy these insights into Pluristem Therapeutics, a world-class leader in cell therapy manufacturing and placental-derived products. [Read more…]

Filed Under: Interviews, MSCs Tagged With: clinical trial, interview, placental, Pluristem

Stem Cell Therapy in India – ReeLabs into Diabetes Clinical Trial

September 17, 2018 By Cade Hildreth (CEO) 1 Comment

ReeLabs - Stem cell therapy in India

Stem cell therapy in India is emerging as a new modality within the healthcare system. The progress is supported by numerous innovators within the country. One company forging the way is ReeLabs, a leading stem cell bank in India that is supporting the collection and storage of stem cells, as well as the development of novel stem cell therapeutics.

Diabetes Mellitus in India

According to the World Health Organization (WHO), diabetes mellitus (DM), commonly referred to as diabetes, is a group of metabolic disorders in which there are high blood sugar levels over a prolonged period.  Diabetes mellitus is one of the most common diseases globally.

In India, the prevalence of diabetes is rising, predominantly related to factors such as genetic factors, stress, diet, obesity, lack of meaningful exercise and lifestyle related issues. [Read more…]

Filed Under: Cord Blood Tagged With: placental, ReeLabs

How the Cord Blood and Tissue Market is Changing

July 27, 2018 By Cade Hildreth (CEO) Leave a Comment

What Are the Benefits of Banking Cord Blood Inside The Cost Of Cord Blood Banking

The global cord blood and tissue banking market is consolidating, driven by the emergence of holding companies and aggressive M&A activity. This is creating risks for cord blood market participants, as well as new opportunities.

Serious threats to the industry include:

  • Low rates of stored cord blood utilization
  • Utilization of bone marrow and peripheral blood stem cells as alternative sources of stem cells for HSCT
  • Growing prevalence of haploidentical transplantation
  • Expensive transplant procedures, ranging from $200-300K
  • Difficulty educating Obstetricians about the future value of cellular therapies
  • Low rates of market penetration
  • Low rates of cord blood awareness among expectant parents

[Read more…]

Filed Under: Cord Blood Tagged With: cord blood, cord tissue, placental

Celularity – Big Bucks, Billionaire Investors, Bold Dreams

May 18, 2018 By Cade Hildreth (CEO) Leave a Comment

Celularity Celularity is a biotechnology company that specializes in leveraging biologically active cell populations within the postpartum human placenta. Founded on the pioneering work of Robert Hariri, MD, PhD, in human placenta-derived cellular therapeutics and biomaterials, Celularity is uniquely positioned to harness the potential of most biocreative event on earth: human birth.

I had the honor of interviewing Celularity’s CEO, Dr. Robert Hariri, a pioneer and visionary within the stem cell industry. As a surgeon, biomedical scientist and serial entrepreneur, Dr. Hariri was previously the Founder and CEO of one of the world’s largest human cellular therapeutics companies, Celgene Cellular Therapeutics, a division of Celgene Corporation. In August 2017, Hariri brought Celularity Inc. into the spotlight by announcing a successful Series A financing with contributions from influential investors, including Sorrento Therapeutics, United Therapeutics Corporation, and Human Longevity, Inc. (HLI).

On February 15th, 2018, the company broke even bigger news when it announced that it had raised $250 million in funding, with contributions from the Genting Group, Tony Robbins, and Dreyfus Family Office, among others.

Below is Part 2 of a two-part interview with Celularity’s CEO, Dr. Robert Hariri. Click here to read Part 1.

[Read more…]

Filed Under: CAR-T, Cell Therapy, Interviews, Stem Cells Tagged With: CAR-T, Celularity, placental

  • 1
  • 2
  • 3
  • Next Page »

Nanocellect

Marathon Products

Let’s Get Social

  • Facebook
  • Twitter
  • Instagram
  • Pinterest
  • LinkedIn
Menu
  • Blog
  • Stem Cell News
    • Press Releases
  • Stem Cells
    • HSCs
    • iPS Cells
    • MSCs
    • Neural Stem Cells
    • Adipose SCs
  • Exosomes
  • Cell Therapy
    • CAR-T
  • Cord Blood
  • Interviews

Cart

Top Rated Products

  • Cell Therapy Manufacturing Survey - Selection Criteria for Choosing a CMO Partner
    Evaluat la 0 din 5
    $197 $97
  • Stem Cell Fact Sheet - Types of Stem Cells and their Use in Medicine
    Evaluat la 0 din 5
    $10
  • Global Database of Research Supply Companies Global Database of Research Supply Companies 2021
    Evaluat la 0 din 5
    $39
My Tweets

BioInformant's World-Class Clients

  • Submit Press Release
  • Advertise
  • Privacy and Terms

Copyright © 2021 · BIOINFORMANT, Your Global Leader in Stem Cell Market Research

| Email: [email protected] | Phone: 703-859-7617 |

800 Corporate Drive, Suite 301, Stafford, VA 22554, United States

Disclaimer: All statements made on this website are NOT expressed as medical claims or advice. They are not intended to diagnose, treat, cure or prevent any disease or condition. If you have a health condition or concern, consult your physician or health care provider.